← Back to all trials
Not Yet Recruiting
NCT07640373
Coping Strategies, Loneliness, and Resilience in Patients With Dermatosis
Conditions: Skin Disease, Skin Disorder, Skin Condition, Inflammatory Skin Conditions, Autoimmune Skin Diseases, Cancerous Skin Conditions, Genetic Skin Conditions
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 375
Sponsor: University Hospital, Brest
Location: CHU Brest Brest
Summary
The European Society for Dermatology \& Psychiatry (ESDaP) studies the connection between the skin and the mind. Two previous studies of this type were conducted in 13 and 15 European countries, respectively. The first study assessed the psychological impact of skin diseases (anxiety, depression, sleep disorders), and the second analyzed feelings of stigma, stress, and body dysmorphic disorder (an abnormal perception of one's body).
In this study, new psychological variables will be examined: coping strategies, loneliness, and resilience.
A total of 23 centers will participate in the ESDaP3 study, located in 15 European countries (Austria, France, Germany, Hungary, Italy, North Macedonia, the Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Turkey, and the United Kingdom).
The aim of this study is to examine coping strategies, loneliness, and resilience among patients with a skin condition. Coping strategies refer to the various ways a person uses to manage a difficult or stressful situation. Resilience refers to a person's ability to cope with difficult situations, adapt to changes or challenges, and regain a sense of balance despite obstacles. Other factors will be assessed: sleep, anxiety and depression, and quality of life. A questionnaire will be given to your potential partner to assess the impact of the skin condition on their life at this time.
At the study's sole French site, Brest University Hospital, 250 patients with a skin condition and 125 people without a skin condition will be enrolled.
Eligibility Criteria
Inclusion Criteria:
* Patients with skin conditions (inflammatory, autoimmune, cancerous, or genetic skin disorders)
* Controls: individuals without skin disease
* Adult participant
* Participant enrolled in a Social Security system or equivalent
* Participant who has given consent to participate in the study
Exclusion Criteria:
* Participants who are unable to understand the protocol
* Participants under legal guardianship (guardianship, conservatorship)
* Participants subject to a future protection order, family authorization, or court-ordered protection
* Participants who are unable to complete the questionnaires
Source: ClinicalTrials.gov (NCT07640373). StuddyBuddy aggregates publicly available trial information.